Rationale
Pediatric COVID‐19 studies have been mostly restricted to case reports and small case series, which have prevented the identification of specific pediatric lung disease patterns in COVID‐19. The overarching goal of this systematic review and meta‐analysis is to provide the first comprehensive summary of the findings of published studies thus far describing COVID‐19 lung imaging data in the pediatric population.
Methods
A systematic literature search of PubMed was performed to identify studies assessing lung‐imaging features of COVID‐19 pediatric patients (0–18 years). A single‐arm meta‐analysis was conducted to obtain the pooled prevalence and 95% confidence interval (95% CI).
Results
A total of 29 articles (n = 1026 children) based on chest computerized tomography (CT) images were included. The main results of this comprehensive analysis are as follows: (1) Over a third of pediatric patients with COVID‐19 (35.7%, 95% CI: 27.5%–44%) had normal chest CT scans and only 27.7% (95% CI: 19.9%–35.6%) had bilateral lesions. (2) The most typical pediatric chest CT findings of COVID‐19 were ground‐glass opacities (GGO) (37.2%, 95% CI: 29.3%–45%) and the presence of consolidations or pneumonic infiltrates (22.3%, 95% CI: 17.8%–26.9%). (3) The lung imaging findings in children with COVID‐19 were overall less frequent and less severe than in adult patients. (4) Typical lung imaging features of viral respiratory infections in the pediatric population such as increased perihilar markings and hyperinflation were not reported in children with COVID‐19.
Conclusion
Chest CT manifestations in children with COVID‐19 could potentially be used for early identification and prompt intervention in the pediatric population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.